Interestingly, we found that CMTM6/CMTM4 and PD-L1 co-localized in macrophages are associated with lower OS in glioma, suggesting that CMTM6/CMTM4 may be specific companion diagnostic biomarkers for immunotherapy in gliomas. Here, CMTM6 is linked to central nervous system cancer.